Skip to main content

letter

. 1995 Jul;71(837):444–445. doi: 10.1136/pgmj.71.837.444-a

Chronic myeloid leukaemia and allogenic bone marrow transplantation in a patient with toxic oil syndrome.

P Llamas-Sillero, M Gómez-Roncero, R Forés, R Cabrera, J L Díez, M N Fernández

PMCID: PMC2397969 PMID: 7567747

444

Images in this article

Figure
on p.445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Alonso-Ruiz A., Calabozo M., Perez-Ruiz F., Mancebo L. Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients. Medicine (Baltimore) 1993 Sep;72(5):285–295. doi: 10.1097/00005792-199309000-00001. [DOI] [PubMed] [Google Scholar]
Martinez-Tello F. J., Navas-Palacios J. J., Ricoy J. R., Gil-Martín R., Conde-Zurita J. M., Colina-Ruiz Delgado F., Tellez I., Cabello A., Madero-García S. Pathology of a new toxic syndrome caused by ingestion of adulterated oil in Spain. Virchows Arch A Pathol Anat Histol. 1982;397(3):261–285. doi: 10.1007/BF00496569. [DOI] [PubMed] [Google Scholar]
Phelps R. G., Fleischmajer R. Clinical, pathologic, and immunopathologic manifestations of the toxic oil syndrome. Analysis of fourteen cases. J Am Acad Dermatol. 1988 Feb;18(2 Pt 1):313–324. doi: 10.1016/s0190-9622(88)70046-8. [DOI] [PubMed] [Google Scholar]
Tabuenca J. M. Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet. 1981 Sep 12;2(8246):567–568. doi: 10.1016/s0140-6736(81)90949-1. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES